Furthermore, the corresponding cancer samples were divided into two groups with high- and low-MAP4K4 expressions based on the median value of the MAP4K4 expression, and then the chi-squared test was performed on the clinical data to analyze whether the sub-classification of various clinical data was related to the distinction between high- and low-MAP4K4-expression samples (Table 3). The gene discussed is MAP4K4; the disease is cancer.